Phase I/II study of neoadjuvant bevacizumab, erlotinib and 5-fluorouracil with concurrent external beam radiation therapy in locally advanced rectal cancer
Titel:
Phase I/II study of neoadjuvant bevacizumab, erlotinib and 5-fluorouracil with concurrent external beam radiation therapy in locally advanced rectal cancer
Auteur:
Blaszkowsky, L.S. Ryan, D.P. Szymonifka, J. Borger, D.R. Zhu, A.X. Clark, J.W. Kwak, E.L. Mamon, H.J. Allen, J.N. Vasudev, E. Shellito, P.C. Cusack, J.C. Berger, D.L. Hong, T.S.